Tag: Adstiladrin

Cell and Gene Therapy, FDA, Industry, Regulations

FDA approves Adstiladrin as first gene therapy for NMIBC

December 19, 2022

Via: Pharmaphorum

Bladder cancer is one of the more common forms of cancer. According to the Centers for Disease Control and Prevention, about 57,000 men and 8,000 women are diagnosed with bladder cancer annually, and roughly 12,000 men and 4,700 women die […]